Asahi Intecc Co., Ltd. (TYO: 7747)
Japan
· Delayed Price · Currency is JPY
2,524.50
+40.50 (1.63%)
Jan 20, 2025, 3:30 PM JST
Asahi Intecc Revenue
Asahi Intecc had revenue of 31.18B JPY in the quarter ending September 30, 2024, with 8.61% growth. This brings the company's revenue in the last twelve months to 110.02B, up 14.42% year-over-year. In the fiscal year ending June 30, 2024, Asahi Intecc had annual revenue of 107.55B with 19.36% growth.
Revenue (ttm)
110.02B
Revenue Growth
+14.42%
P/S Ratio
6.30
Revenue / Employee
11.74M
Employees
9,371
Market Cap
693.46B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 107.55B | 17.45B | 19.36% |
Jun 30, 2023 | 90.10B | 12.35B | 15.89% |
Jun 30, 2022 | 77.75B | 16.24B | 26.41% |
Jun 30, 2021 | 61.51B | 4.96B | 8.77% |
Jun 30, 2020 | 56.55B | -670.00M | -1.17% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,142.35B |
Daiichi Sankyo Company | 1,758.07B |
HOYA Corporation | 812.74B |
Takeda Pharmaceutical Company | 4,546.08B |
Otsuka Holdings | 2,269.56B |
Terumo | 986.67B |
Astellas Pharma | 1,772.16B |
Olympus | 973.60B |